C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks
Authors
Foster, GR; Agarwal, K; Cramp, M; Moreea, S; Barclay, ST; Collier, J; Brown, AS; Ryder, SD; Ustianowski, A; Forton, DM; Fox, R; Gordon, F; Rosenberg, WM; Mutimer, DJ; Du, J; Gilbert, CL; Wahl, J; Barr, E; Haber, BCollections
- Immune Systems [204]
Copyright statements
